BackSanofi Overview

Sanofi Receivables

Track Sanofi's receivables ($490M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$492.00M
↓ 94.01% YoYΔ $-7.71B vs prior year quarter

Peer trimmed avg / median

Loading

Sanofi Receivables History

Loading

Sanofi vs. peers: Receivables Comparison

Loading

Sanofi Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sanofi (SNYNF) FAQ

Sanofi (SNYNF) currently reports a receivables of $490M as of June 2026. That compares with $8.2B in the prior-year period — down 94.0% year over year. Use the charts on this page to explore Sanofi's receivables history and peer comparisons.

Sanofi's receivables decreased from $8.2B to $490M — a 94.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sanofi reported $490M in receivables as of June 2026. That compares with $8.2B in the prior-year period — down 94.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $490M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sanofi, and consider following SNYNF for alerts when major investors trade the stock.

Sanofi is classified in the Healthcare sector. On receivables, it currently shows $490M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNYNF with unrelated industries.